← Back to home

About Kovaris

A Buenos Aires firm working in five Latin American markets.

Kovaris Health Strategy is a market intelligence, pricing and access consultancy for the pharmaceutical industry, founded in 2026 by Guadalupe Viveros. The firm works with pharma companies, biotechs and distributors with decisions pending in Argentina, Mexico, Paraguay, Uruguay and Chile, with a focus on high-cost and rare diseases.

Guadalupe Viveros, founder and director

Degree in Business Economics from Universidad Torcuato Di Tella. More than twelve years in strategy consulting and market access for pharma, as a consultant at IQVIA for pharmaceutical clients in the Southern Cone (2014 to 2016), Principal Consultant at a pharma-focused consultancy, with more than 50 projects for pharma and biotech in Latin America, Europe and the United States (2016 to 2024), and independent strategy consultant for pharma teams in the region (2024 to 2026).

LinkedIn profile →

The KHIN network

The Kovaris Health Intelligence Network is the firm's own network of relationships with physicians, opinion leaders, payers, regulatory experts, institutions and patient organizations in the five markets. It was built project by project over more than a decade and brings the perspective of the system's decision makers into the analysis. It is managed with informed consent, anonymization and adverse event reporting; the identity of its members is not disclosed under any circumstances.

Areas of work

High-cost and rare diseases: hereditary angioedema, specialty hematology and immunology, immunoglobulins, metabolic disorders, specialty neurology and respiratory, hemato-oncology, and cell and gene therapies. Markets: Argentina and Mexico as main markets; Paraguay, Uruguay and Chile as key markets.

First step: the decision your team needs to make.

An initial 30-minute call is used to set out the question and the scope; the proposal, with the price and the delivery date, follows in writing.